Palatin Technologies
PTN
#10894
Rank
โ‚น1.19 B
Marketcap
โ‚น671.51
Share price
14.04%
Change (1 day)
-40.48%
Change (1 year)

Palatin Technologies (PTN) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚น0.17 Billion

According to Palatin Technologies's latest financial reports the company's total liabilities are โ‚น0.17 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Palatin Technologies - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30โ‚น1.46 B-6.56%
2022-06-30โ‚น1.56 B19.16%
2021-06-30โ‚น1.31 B254.93%
2020-06-30โ‚น0.36 B28.12%
2019-06-30โ‚น0.28 B-65.02%
2018-06-30โ‚น0.82 B-79.41%
2017-06-30โ‚น4.00 B108.66%
2016-06-30โ‚น1.92 B74.83%
2015-06-30โ‚น1.09 B561.04%
2014-06-30โ‚น0.16 B33.16%
2013-06-30โ‚น0.12 B-36.69%
2012-06-30โ‚น0.19 B48.22%
2011-06-30โ‚น0.13 B-6.72%
2010-06-30โ‚น0.14 B-69.88%
2009-06-30โ‚น0.47 B-12.33%
2008-06-30โ‚น0.53 B-45.1%
2007-06-30โ‚น0.98 B-2.47%
2006-06-30โ‚น1.00 B-10.7%
2005-06-30โ‚น1.12 B192.92%
2004-06-30โ‚น0.38 B104.46%
2003-06-30โ‚น0.18 B4.99%
2002-06-30โ‚น0.17 B63.92%
2001-06-30โ‚น0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚น10.884 T 6,307,542.91%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น6.148 T 3,562,725.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น156.42 B 90,544.88%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
โ‚น0.29 B 72.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น114.42 B 66,209.28%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น84.23 B 48,713.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
โ‚น0.24 B 42.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
โ‚น40.09 B 23,133.01%๐Ÿ‡บ๐Ÿ‡ธ USA